| ■ FDA Expands Johnson & Johnson Children's Drug Probe | 2010.05.21 |
| Johnson & Johnson, which recently recalled more than 40 children's medicines, is coming under more government scrutiny, according to the U.S. Food and Drug Administration. The FDA said it is expanding its investigation and looking into manufacturing within the company's consumer health-care unit, McNeil Consumer Healthcare, which makes Benadryl, St. Joseph aspirin, Motrin, Tylenol and Zyrtec, among other products for children and adults, the Wall Street Journal reported. Last month, the company recalled some over-the-counter medicines for children and infants, and closed the Fort Washington, Pa., plant where the recalled products were made. An FDA spokeswoman said the agency wanted to make sure similar manufacturing problems didn't exist at McNeil unit plants in Lancaster, Pa., and Las Piedras, Puerto Rico. As a result of the recall, a congressional committee is looking into how the company handles consumer complaints and reviewing the FDA's inspection procedures. Johnson & Johnson's chief executive, William Weldon, has been asked to testify at a hearing on May 27, the Journal said. |